Prasugrel

Generic Name
Prasugrel
Brand Names
Effient, Efient, Prasugrel Viatris (previously Prasugrel Mylan)
Drug Type
Small Molecule
Chemical Formula
C20H20FNO3S
CAS Number
150322-43-3
Unique Ingredient Identifier
34K66TBT99
Background

Prasugrel, a thienopyridine derivative, is a platelet activation and aggregation inhibitor structurally and pharmacologically related to clopidogrel and ticlopidine. Similar to clopidogrel, prasugrel is a prodrug that requires enzymatic transformation in the liver to its active metabolite, R-138727. R-138727 irreversibly binds to P2Y12 type ADP receptors on ...

Indication

用于心力衰竭、卒中、不稳定心绞痛等心脑血管疾病以及有急性冠状动脉综合征需要进行经皮冠脉介入术的患者。

Associated Conditions
Cardiovascular Events
Associated Therapies
-

A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease

Phase 2
Completed
Conditions
Interventions
First Posted Date
2011-11-22
Last Posted Date
2014-02-13
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
33
Registration Number
NCT01476696
Locations
🇺🇸

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Pittsburgh, Pennsylvania, United States

Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE Trial

Phase 3
Completed
Conditions
Interventions
First Posted Date
2011-11-06
Last Posted Date
2012-03-27
Lead Sponsor
Gennaro Sardella
Target Recruit Count
30
Registration Number
NCT01465828
Locations
🇮🇹

Dept.of Cardiovascular Sciences,Policlinico Umberto I, Rome, Italy

Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)

Phase 4
Completed
Conditions
Interventions
First Posted Date
2011-11-01
Last Posted Date
2012-07-11
Lead Sponsor
University of Patras
Target Recruit Count
27
Registration Number
NCT01463150
Locations
🇬🇷

Cardiology Department Patras University Hospital, Rio, Achaia, Greece

Ticagrelor in Comparison to Prasugrel for Early Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)

Phase 4
Completed
Conditions
Interventions
First Posted Date
2011-11-01
Last Posted Date
2012-04-10
Lead Sponsor
University of Patras
Target Recruit Count
50
Registration Number
NCT01463163
Locations
🇬🇷

Cardiology Department Patras University Hospital, Rio, Achaia, Greece

Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing

First Posted Date
2011-10-20
Last Posted Date
2013-11-01
Lead Sponsor
Deutsches Herzzentrum Muenchen
Target Recruit Count
70
Registration Number
NCT01456364
Locations
🇩🇪

Deutsches Herzzentrum, München, Bavaria, Germany

🇩🇪

Klinikum der Ludwig-Maximilians-Universität München, München, Bavaria, Germany

🇭🇺

Heart Center Balatonfüred, Dept. of Cardiology, Balatonfüred, Hungary

Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI)

Phase 2
Completed
Conditions
Interventions
First Posted Date
2011-10-14
Last Posted Date
2013-04-25
Lead Sponsor
Ottawa Heart Institute Research Corporation
Target Recruit Count
102
Registration Number
NCT01452139
Locations
🇨🇦

University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study

First Posted Date
2011-10-14
Last Posted Date
2022-03-16
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
9
Registration Number
NCT01452152
Locations
🇺🇸

Christiana Care Health System, Newark, Delaware, United States

🇺🇸

University of Maryland School of Medicine, Baltimore, Maryland, United States

🇺🇸

Sinai Center for Thrombosis Research, Baltimore, Maryland, United States

and more 2 locations

The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of Clopidogrel

Phase 4
Completed
Conditions
Interventions
First Posted Date
2011-06-03
Last Posted Date
2020-09-09
Lead Sponsor
Medstar Health Research Institute
Target Recruit Count
77
Registration Number
NCT01365221
Locations
🇺🇸

The Heart Center, Huntsville, Alabama, United States

🇺🇸

Washington Hospital Center, Washington, District of Columbia, United States

🇺🇸

Sinai Center for Thrombosis Research, Baltimore, Maryland, United States

and more 1 locations

Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention

First Posted Date
2011-05-25
Last Posted Date
2012-06-22
Lead Sponsor
University of Patras
Target Recruit Count
44
Registration Number
NCT01360437
Locations
🇬🇷

Cardiology Department Patras University Hospital, Rio, Patras, Greece

Pharmacokinetic Interaction Between Ritonavir and Prasugrel in Healthy Volunteers

Phase 1
Completed
Conditions
Interventions
First Posted Date
2011-05-03
Last Posted Date
2011-10-06
Lead Sponsor
University Hospital, Geneva
Target Recruit Count
10
Registration Number
NCT01346800
Locations
🇨🇭

University Hospitals, Geneva 14, Switzerland

© Copyright 2024. All Rights Reserved by MedPath